Literature DB >> 11694326

The regulation of alpha chemokines during HIV-1 infection and leukocyte activation: relevance for HIV-1-associated dementia.

L Poluektova1, T Moran, M Zelivyanskaya, S Swindells, H E Gendelman, Y Persidsky.   

Abstract

Cellular immunity against human immunodeficiency virus type 1 (HIV-1)-infected brain macrophages serves to prevent productive viral replication in the nervous system. Inevitably, during advanced disease, this antiretroviral response breaks down. This could occur through virus-induced dysregulation of lymphocyte trafficking. Thus, we studied the production of non-ELR-containing alpha-chemokines and their receptor (CXCR3) expression in relevant virus target cells. Macrophages, lymphocytes, and astrocytes secreted alpha-chemokines after HIV-1 infection and/or immune activation. Lymphocyte CXCR3-mediated chemotactic responses were operative. In all, alpha-chemokine-mediated T cell migration continued after HIV-1 infection and the neuroinflammatory events operative during productive viral replication in brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11694326     DOI: 10.1016/s0165-5728(01)00413-1

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

Review 1.  CXC chemokine receptors in the central nervous system: Role in cerebellar neuromodulation and development.

Authors:  Davide Ragozzino
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

2.  HIV-1 Tat-mediated neurotoxicity in retinal cells.

Authors:  Nivedita Chatterjee; Shannon Callen; Gail M Seigel; Shilpa J Buch
Journal:  J Neuroimmune Pharmacol       Date:  2011-01-28       Impact factor: 4.147

3.  Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis.

Authors:  Raghava Potula; Larisa Poluektova; Bryan Knipe; Jesse Chrastil; David Heilman; Huanyu Dou; Osamu Takikawa; David H Munn; Howard E Gendelman; Yuri Persidsky
Journal:  Blood       Date:  2005-06-16       Impact factor: 22.113

Review 4.  HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication.

Authors:  Jonathan Herskovitz; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2018-03-23       Impact factor: 4.147

5.  CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10.

Authors:  Maxim C-J Cheeran; Shuxian Hu; Wen S Sheng; Phillip K Peterson; James R Lokensgard
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 6.  Neuroprotective strategies for HIV-1 associated dementia.

Authors:  Huanyu Dou; Jeffrey D Kingsley; R Lee Mosley; Harris A Gelbard; Howard E Gendelman
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

7.  Molecular mechanism(s) involved in the synergistic induction of CXCL10 by human immunodeficiency virus type 1 Tat and interferon-gamma in macrophages.

Authors:  Navneet Dhillon; Xuhui Zhu; Fuwang Peng; Honghong Yao; Rachel Williams; Jianming Qiu; Shannon Callen; Amy O'Brien Ladner; Shilpa Buch
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

8.  Decreased CXCR3+ CD8 T cells in advanced human immunodeficiency virus infection suggest that a homing defect contributes to cytotoxic T-lymphocyte dysfunction.

Authors:  Diana M Brainard; Andrew M Tager; Joseph Misdraji; Nicole Frahm; Mathias Lichterfeld; Rika Draenert; Christian Brander; Bruce D Walker; Andrew D Luster
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

9.  Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis.

Authors:  Adeline Nukuna; Howard E Gendelman; Jenae Limoges; Jennifer Rasmussen; Larisa Poluektova; Anuja Ghorpade; Yuri Persidsky
Journal:  J Neurovirol       Date:  2004       Impact factor: 2.643

Review 10.  Role of trophic factors on neuroimmunity in neurodegenerative infectious diseases.

Authors:  Dianne Langford; Eliezer Masliah
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.